Add to ORKGPancreatic cancer is the 7th most common cause of cancer mortality in the world. It is predicted to become the second leading cause of cancer-related death in 2030. Myoferlin is a 230 kDa protein overexpressed in pancreatic cancer. Recently, our team showed a fragmentation of the mitochondrial network in PDAC cells when myoferlin was depleted using siRNA. Understanding the mechanism underlying this mitochondrial disruption would be of great interest as mitochondria are major actors in cancer development, progression and resistanceRole of myoferlin in mitochondrial dynamics and metabolic fitness of pancreatic cance
peer reviewedMyoferlin, an emerging oncoprotein, has been associated with a low survival in several ...
Pancreatic cancer is one of the deadliest types of malignant diseases. Asymptomatic early tumour sta...
Lysosomes must maintain the integrity of their limiting membrane to ensure efficient fusion with inc...
Pancreatic cancer has one of the lowest survival rates with more than 90% of patients dying of the d...
Pancreas ductal adenocarcinoma is one of the deadliest cancers where surgery remains the main surviv...
Pancreatic cancer is the 7th most common cause of cancer mortality in the world. It is predicted to ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and the third ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and the third ...
Our data strongly suggest that myoferlin interacts with MFN. Indeed, if myoferlin is a part of the m...
peer reviewedPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies with an ov...
peer reviewedPancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related de...
International audienceMyoferlin is a multiple C2-domain-containing protein that regulates membrane r...
Myoferlin is a multiple C2-domain-containing protein that regulates membrane repair, tyrosine kinase...
Pancreatic ductal adenocarcinoma (PDAC) is the seventh leading cause of cancer-related deaths worldw...
Despite intensive research, Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the deadliest for...
peer reviewedMyoferlin, an emerging oncoprotein, has been associated with a low survival in several ...
Pancreatic cancer is one of the deadliest types of malignant diseases. Asymptomatic early tumour sta...
Lysosomes must maintain the integrity of their limiting membrane to ensure efficient fusion with inc...
Pancreatic cancer has one of the lowest survival rates with more than 90% of patients dying of the d...
Pancreas ductal adenocarcinoma is one of the deadliest cancers where surgery remains the main surviv...
Pancreatic cancer is the 7th most common cause of cancer mortality in the world. It is predicted to ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and the third ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and the third ...
Our data strongly suggest that myoferlin interacts with MFN. Indeed, if myoferlin is a part of the m...
peer reviewedPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies with an ov...
peer reviewedPancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related de...
International audienceMyoferlin is a multiple C2-domain-containing protein that regulates membrane r...
Myoferlin is a multiple C2-domain-containing protein that regulates membrane repair, tyrosine kinase...
Pancreatic ductal adenocarcinoma (PDAC) is the seventh leading cause of cancer-related deaths worldw...
Despite intensive research, Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the deadliest for...
peer reviewedMyoferlin, an emerging oncoprotein, has been associated with a low survival in several ...
Pancreatic cancer is one of the deadliest types of malignant diseases. Asymptomatic early tumour sta...
Lysosomes must maintain the integrity of their limiting membrane to ensure efficient fusion with inc...